Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by cactuseskimoon Apr 03, 2021 3:51pm
96 Views
Post# 32934173

RE:Price on monday

RE:Price on monday

I mostly plan on getting out on Monday if we do a decent gap-up as well. Share price is all about current opinion and momentum - and right now, even though the numbers were good for Q4 (which should have helped opinion and momentum), opinion of the stock has definitely taken a hit with this "dissapointing" development in company direction, and momentum was definitely squandered when they decided to release their Q4 report late, after hours, at the beginning of a weekend, and an extra long weekend at that. Ughh, what a gong show that was. Still having a hard time fathoming it. .


Cutman wrote: A lot of people looks optimistic for the price like a gap up and back around 1.40 ish. As an investor, I have been shocked after the CC and im starting to think about selling half of my position. The numbers are good but really, I'm losing confidence towards the CEO and the compagny itself. I don't know what to think about the future. We have to grow but 23M shares is a lot, specialy after a RS and a dilution within 1 month. My opinion Hope I'm wrong

 

<< Previous
Bullboard Posts
Next >>